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Tins investigation was undertaken to bring up to date the records of the
Middlesex Hospital, and to attempt to discover whether there was any statistical
evidence to support commonly held views on factors affecting prognosis and
methods of treatment. 836 cases of carcinoma of the female breast treated
during the years 1926-35 were analysed and a smaller group of 265 cases, treated
during the years 1936-40, were the subject of a further investigation to discover
the effect of more modern methods of treatment.
The hopes held at the start of this work have not been completely fulfilled.
For such an investigation to give a clear cut statistical answer to all ofthe contro-
versial questions, careful planning and equal distribution of cases, according to
the extent of the disease and type of treatment used, would be necessary. This
was not so in this series of cases. As a result the evidence on some points is too
inconclusive to give an answer.
Careful analysis of results would seem to be essential if methods of treatment
are to be guided by fact rather than by impressions. If, in the future, reliable
figures on a large scale are to be obtained, co-ordination of policy in treatment
and planning ahead in large medical formations will be necessary. Whether this
is acceptable or desirable may be open to argument, for it must inevitably mean
some acceptance by each individual surgeon of the combined opinion of his
colleagues. Only thus, however, can the successful analysis of large series be
substituted for the analysis of smaller series for individual surgeons.
Despite the difficulties that have arisen owing to the many variations in
technique during the years covering this investigation, certain facts that may be
of interest and value have emerged. Some previously held views have been
supported; others appear to be incorrect.
The histological findings in this series have been omitted owing to the imprac-
ticability of examining over 1000 sections in the time available. This in itself
would make the basis of a separate inquiry. From the statistical point of view
therefore it has been assumed that any variations in the histological grouping
of the growths have been spread evenly throughout the series.
The presentation ofresults of an investigation such as this is difficult. While
the actual detailed figures and tables by which conclusions have been reached are
ofimportance, their inclusion in the text would make reading wearisome. There-
fore simplified tables only have been included.
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The investigation has been made on the following plan:
1. The fate of 836 cases after ten years.
2. The influence of factors on this result:
(a) The clinical state of the growth at the start of treatment.
(b) The site of the growth in the breast.
(c) The age of the patient.
3. The treatments employed and their results.
4. Symptomatology.
5. Recurrences,theirdistributionand relation to thesite oftheprimarygrowth.
6. The 10-15-year period after treatment.
Method of investigation.
Material.
All cases that came for treatment during 1926-35 have been included with the
following exceptions: some whose records could not be found; some on whom
there was insufficient information; some who were considered too far advanced
for any treatment; some operated on elsewhere and sent for prophylactic radio-
therapy or for treatment of recurrences.
Collection of data and cases.
All information on the original condition and the treatment has been extracted
from the notes made at that time. Subsequent progress has been followed from
records kept by the hospital follow-up department. Where there has been a
long interval since the last visit or letter, an attempt has been made to complete
the information by writing to the patient. This has been successful in a fair
proportion of cases, but there are many that seem to be untraceable since their
evacuation or forcible eviction by enemy action during the war.
Deaths.
Information as to the cause of death is largely from the general practitioner.
Post-mortem examinations were not done on the majority, and the recorded
cause of death may not always be completely accurate. It would seem unlikely
that this small potential error has affected the results to any marked degree.
Recording of result and length of follow-up.
One of the following results was possible for each patient at the end of five,
ten and fifteen years: alive and well; alive with a recurrence; untraced; dead.
If dead the cause of death could be due to carcinoma of the breast, to other
causes or to unknown causes.
The length of follow-up was until July, 1946, so the maximum was twenty
years and the minimum was ten years. For the purpose of comparing factors
affecting the result and to conform with other published series two time intervals
have been used-the 5 years and 10 years from treatment. While the results
at the end of fifteen years were of considerable initerest, they were not sufficiently
consistent in follow-up to be used for comparisons.
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Method of expressing result.
Recording ofthe result according to the six possible fates previously mentioned
is too cumbersome to allow easy assessment of the effects of varying factors.
Those alive at the end of each period are successes and those dying of carcinoma
are failures, but those in between fall into neither class. A case dying of other
causes or of unknown causes cannot really be called a success or a failure.
Two ways of expressing the result seem to be possible-the survival rate or
the mortality rate. The former has the advantage that it allows easier comparison
with previous series that are almost universally expressed in terms of survival
(or cure) rates. It would appear, however, that results expressed in terms of
those actually dying of carcinoma of the breast will give a more accurate picture
of effects of various factors influencing the prognosis.
For these reasons the "mortality rate" has been used as a routine in this
paper. It has been expressed as the percentage ofthose cases deadfrom carcinoma
of the breast of all traced cases. The survival rate has also been recorded, as it
may be of interest for comparison with other series.
1. The Fate of 836 Cases of Carcinoma of the Breast Ten Years after Treatment.
The following table shows the end-result of all stages of carcinoma of the
breast after treatment
Result. Number.
Alive . . . . . . 94 (11 0 per cent)
Dead:
From operation . . . . 20 ( 25 ,, )
,, carc. mammae . . . 513 (61-5 ,,
,, other cause . . . 62 ( 80 ,, )
,, unknown cause. . . 48 ( 60 ,, )
Untraced . . . . . . 99 (11.0 ,, )
836
The mortality rate from carcinoma of the breast is therefore 533 cases out
of 737 traced cases, or 72.3 per cent, and the survival rate is 94 out of 737 traced
cases, or 12.75 per cent. This mortality rate means that three out of every
four women coming for treatment during these years died of carcinoma of the
breast within ten years. These figures can only have a disturbing effect on any
feeling of satisfaction or complacency with the treatment of carcinoma in an
area that has been recognized as one of the most approachable.
2. The Influence of Factors on the Result.
a. The clinical state of the growth at the start of treatment.
Each case was put into stages according to the extent of the growth at the
start of treatment.
The following stages were used:
Stage l.-Growth in breast not infiltrating skin or muscle, not involving
axillary glands, no other metastasis. (Slight attachment to skin or muscle was
not considered as infiltration.)
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Stage II.-Growth as above but with involvement of axillary glands. This
involvement was on histological grounds if possible, but in cases where this had
not been done clinical enlargement was taken as involvement.
Stage III.-(a) Growth in breast with skin infiltration or ulceration without
axillary gland'involvement.
(b) Growth in breast with skin infiltration or ulceration with axillary gland
involvement.
Stage IV.-As in Stage I-III, but with distant metastasis, supraclavicular
glands to count as distant metastasis.
The results of all treatment were determined for each stage of growth. The
simplified tables read as follows:
Mortality Rate at Five Years and Ten Years.
Percentage mortality rate.
Stage of growth. _ _-
years. 10 years.
I . . . . . . 36.2 . 53.0
II . . . . . 69.0 . 75.0
IIIa . . . . . 73.7 . 73-7
IIIb . . . . . 88*2 . 93.5
The striking feature about these tables is the marked difference between the
results for Stage I and Stage II growths. There is a 33 per cent difference in the
mortality rate at five years if the axillary glands show involvement. The
standard error of difference is 3.6 per cent; the measured difference is more than
eight times this and is, therefore, highly significant. These figures bear out the
reports of others as to the great importance on prognosis of examination of the
axillary glands histologically (Scarff and Handley, 1938; Leeds Report, 1926).
The figures for Stage III growths are based on a small number of cases, but
they suggest that ulceration of the skin even when the axillary glands are free
from growth is of bad prognosis. When both ulceration and axillary gland
involvement are present as in Stage IIIb cases the outlook is gloomy in the
extreme.
The survival rate for Stage I cases is 51-4 per cent. This appears poor when
compared with other series, but it should be remembered that this figure includes
only those cases alive. Any case dying of unknown cause or other cause in this
method of calculating the survival rate would be counted as a failure. If such
cases are excluded from the total the figure would be very close to 60 per cent.
A point that is striking is the number of cases that die from a carcinoma of
the breast during the 5-10-year period. There is a consistent increase in mor-
tality rates. at the ten-year interval for all stages of growth. In Stage I cases
75 patients died during the first five years and a further 24 in the second five
years. Again this was pointed out by Scarff and Handley in their paper. In
this investigation it has been found that there is even a mortality after ten years.
In 250 Stage I cases a further 6 died between the 10th and 15th years. This
point is further elaborated in Section 6 ofthis paper.
Further analysis of Stage I cases into the effect of slight attachment to skin or deep
tissues.
Although all Stage I cases were free from infiltration of the skin or deep
tissues, some of them had a certain degree of attachment or "tethering." To
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determine whether or not this was of importance in the prognosis, a further sub-
division was made into cases with early attachment and cases without attachment
and the mortality rate determined for each.
There were 125 ofeach type and the mortality rates were as follows:
Mortality Rates at Five and Ten Years.
~~Stage. ~Percentage Percentage
a years. 10 years.
I, no attachment . . . 31 . 51
I, slight attachment . . . 38 . 55
These differences are too small to be of statistical significance in this number
of cases, but the table suggests that attachment had an adverse effect on the
prognosis. A further subdivision was made of cases with slight attachment into
those with attachment to the skin and those with attachment to deeper tissues.
The mortality rate for these sub-groups was:
Percentage Percentage ~~~~~Stage. ~5 years. 10 years.
Deep attachment . . . 47 . 58
Skin attachment . . . 33 53- 5
It will be noticed that the mortality rate for cases with slight attachment
to the skin is very similar to those with no attachment at all, 33 per cent and 31
per cent, while that for cases with slight attachment to the deep structures is
considerably higher, 47 per cent. On this number of cases the difference is
barely significant, but it would suggest that early attachment to the deep tissues
is of serious import, while slight attachment to the skin does not materially
affect the prognosis.
b. The site of the growth in the breast.
In describing the situation of a growth in the breast the usual subdivision
into quadrants was made. When a growth lay between two quadrants it was
described as lying in a "mid" position. Thus there were the "mid-medial," the
"mid-inferior," the "mid-lateral" and thbe " mid-superior "positions. A growth
lying immediately beneath the nipple or spreading into three or more quadrants
was described as being in the "central " position. A growth lying in the axillary
tail was put under that heading. Tables showing the distribution in all these
positions are too cumbersome, and they have been simplified by dividing growths
in the mid-positions equally between the adjacent quadrants.
The distribution of growths among the quadrants was similar in Stage I and
Stage II growths and the consolidated tables are:
~~~~Quadr&~ant. ~Percentage of growths.
Outer and upper . . . . . 46
Inner and upper . . . . . 20
Central . . . . . . . 13
Outer and lower . . . . . 12
Inner and lower . . . . . 5
Axillarv tail . . . . . . 4
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The rather high incidence of growths in the central position is probably due
to a certain number oflarger growths in Stage II that were not described in suffi-
cient detail to put them into any other quadrant.
To attempt to discover whether there was any difference in the prognosis
between the various sites, the mortality rate for each site for Stage I and II
growths was determined:
Stage I and II Growths. Mortality Rate at 5 Years for Each Site.
Stage I growths. Stage II growths.
~~Site. ~Percentage Percentage
mortality rate mortality rate
5 years. 5 years.
Outer and upper . . 33.5 . 62.0
Inner and upper . . 38.5 . 67.0
Central . . . . 37.0 . 78-0
Outer and lower . . 31-5 . 695
Inner and lower . . 28.5 . 58.5
Axillary tail . . . 33.5 . 73.5
Thesefigures do not show any consistent difference, and thereislittleto suggest
that the site ofthe growth in the breast plays an important part in prognosis. It
may be worthy of note that the inner and lower quadrant has the lowest mor-
tality rate in both Stage I and Stage II growths, being at least 10 per cent lower
than the highest in each group. This agrees with the findings of Perry (1925)
in his series from the London Hospital.
c. The age of the patient.
The average age of the patients in this series was 55 years. The average
age for Stage I growths was 55 years, for Stage II growths 54 years, and for Stage
III growths 59 years.
The incidence of growths in decades was:
Decade. Perc'entage.
0-39 . . . . . . . 8'0
40-49 . . . . . . .26-5
50-59 . . . . . . . 30.0
60-69 . . . . . . . 24 0
70-79 . . . . . . . 10.0
80-89 . . .. . . . 1.5
It is remarkable that the youngest was a girl of eleven, alive and well fifteen
years later. The oldest was a woman of 86.
To determine the effect of age on prognosis the mortality rate was calculated
for each stage and for each decade.
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The consolidated table shows the following result:
Percentage mortality rates.
Decade. ^
5 years. 10 years.
0-39 . . . . . 70 . 81
40-49 , . . .. 59 . 74
50-59 . . . . . 63 . 76
60-69 . . . . . 62 . 79
70-79 . . . . . 56 . 63
80-89 . . . . . 67 . 67
Once again these figures are somewhat disappointing in that they show little
difference between the age groups. The decade 80-89 is a group of 13 cases only
and must be disregarded. Although the mortality rate for group 0-39 is higher
than any other, both for the consolidated table and for each stage separately,
the difference is not so striking as might be expected. There is no support for
the opinion that a carcinoma of the breast in a young woman is invariably fatal.
The prognosis in Stage I growths is little worse than for the other age groups.
3. The Treatments Employed and Their Results.
Methods employed.
All the cases in this series have been treated by the Honorary Surgical Staff
of the Middlesex Hospital during the years 1926-35. The varying methods used
were given according to the wishes and opinions of those surgeons.
Three main types of treatment were used: surgery alone; surgery and radio-
therapy; radiotherapy alone.
In view of the findings in this part of the investigation it should be stressed
thatthetechnique ofradiotherapy was in theprocess of evolution. Indeed, there
was an abrupt change in 1936, and the further investigation on cases treated in
1936-40 modifies the results obtained in this series.
Radiotherapy, when used alone, was either radium implant to the breast in
the Keynes (1932) technique or deep X-ray therapy. When associated with
surgery the radiotherapy was either the implantation of radium into the wound
at the time of operation according to the method described by Sampson Handley
(1922) or prophylactic deep X-ray therapy. The latter was given in multiple
intermittent sub-erythemal doses with medium voltage. The dose was recorded
in "P.D." or "percentage E.D." and appeared to vary considerably. The treat-
ment was carried out for prolonged periods occasionally extending up to three
years, and on several occasoins the prophylactic therapy merged imperceptibly
into treatment of a local recurrence.
Selection of method of treatment.
lf any comparison is to be made of the results of these differing methods of
treatment, one must be sure that there was no tendency to use one method on
the more unfavourable case. It is difficult to assess from the notes why various
methods were used, but one may assume that the standard ofskill over the whole
series was equal. It would seem possible that there was a tendency to use radio-
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therapy on the more extensive case, but this was not by any means invariable.
Some surgeons never used it on any case, no matter how severe, while, in another
large series, radium was employed as a routine at operation.
The group treated by radiotherapy alone were those with concomitant disease
that made them unfit for surgery: those that refused operation and those that
were considered unsuitable for operation, usually owing to the small size of the
breast. There would thllerefore seem to be a case for saying that this group
might be expected to show worse results than the others.
Comnparison of results.
In order to gain a common ground for comparison the results have been
determined for each method of treatment on Stage I and Stage II cases. In
addition, to determine the results in a completely homogeneous early group, the
same figures have been calculated for the earliest type of Stage I case, i.e. those
with no attachment at all.
To simplify the results and to obtain groups of sufficient size for satisfactory
comparison, cases that received any form of radiotherapy as an aid to surgery
have been put under one heading.
Resuqlts of Treatmnent.
Stage I growths.
Percentage Percentage
Method of treatment. mortality mortality
5 years. 10 years.
Surgery alone . . . . 28 . 49
Surgery and radiotherapy . . 47 . 63
Radiotherapy alone . . . 43 . 86
Stage II growths.
Surgery alone . . . . 62 . 72
Surgery and radiotherapy . . 74.5 . 82
Radiotherapy alone . . . 70 . 73
The striking feature about these tables is the mnarked increase in mortality
rate in those cases that received ancillary radiotherapy to surgery over those
treated by surgery alone. In Stage I there is a 19 per cent increase at five years,
which is well over twice the standard error of difference (7 per cent). Simnilar
findings will be seen for Stage II growths.
What interpretation is to be put on these figures? At their face value it
would seem that cases treated with ancillary radiotherapy have a significantly
higher mortality rate, and, to put it bluntly, the use ofradiotherapy was actually
harmfill. This disconcerting result cannot be accepted unless the cases treated
by all methods were homogeneous. As stated above, there may have been a
tendency to send the worse cases for radiotherapy, but it can only have a slight
effect on the result.
To exclude this tendency as far as possible the same mortality rate has been
calculated for the earliest type of Stage I cases. These will be cases with a good
prognosis and equal on clinical grounds. This group gave the following figures:
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Stage I, uwth No Attachment at all.
Percentage Percentage
Method of treatment. mortality mortality
5 years. 10 years.
Surgery alone . . . 25- 5 . 45-5
Surgery and radiotherapy . 43 . 58-5
Radiotherapy alone . . 20 . 545
There were only 125 cases in this class and figures are too small to be of
statistical significance in themselves, but it will be noted that they are in the
samne ratio for the figures for Stage I growths as a whole with regard to surgery
and surgery with radiotherapy. The series treated by radiotherapy alone was
far too small to be of any significance. It is therefore reasonable to infer that
these figures show a true difference in mortalities.
To sum up this evidence, it seems strongly suggested that the results of treat-
ment ofcarcinoma ofthe breast were best, during the years 1926-35, when surgery
only was the method of treatment.
Subsidiary investigation into results of treatment during the years 1936-40.
In the year 1936 a big change took place in the technique of radiotherapy
when used with surgery. Instead of multiple sub-erythemnal doses given over
a prolonged period, the treatment was given in daily doses up to the level of skin
tolerance, using 250 k.v. Once this level had been reached prophylactic treat-
ment was not repeated. The average dosage was 2400 "r" to the skin over
four fields, with a tumour dose of approximately 3500 "r" to the chest wall
and the glands.
This subsidiary investigation has been conducted to try and detexmine whether
the results improved with the change. If any practical value as to the best
method of treatment is to be gained it is obvious that the treatments compared
must be as modern as possible. Unfortunately, owing to the war, the informa-
tion is not as full nor the follow-up as complete as might be wished.
The following mortality rates at five years for Stage I and Stage II growths
treated by surgery and radiotherapy Were found:
Stage I: 5-year mortality rate, 24 per cent.
Stage 11: 5-year mortality rate, 70 per cent.
When these figures are compared with similar figures for the previous period
(47 per cent and 74.5 per cent) it will be seen that there has been considerable
improvement in Stage I and slight improvement in Stage II growths. When
comparing these figures with those achieved by surgery alone the figures for Stage
I growths are slightly better and those for Stage II growths are slightly worse
when radiotherapy was added to surgery. Neither of these differences is, how-
ever, large enough to be significant statistically.
To summarize the whole position, it.may be said that the change of method
of administering radiotherapy since 1936 has resulted in an improvement in the
results achieved by the combination of surgery and radiotherapy. There is
insufficient evidence in this series to say whether the results are better than those
for surgery alone.
137B. MoN. TRUSCOTT
Surgical operations and their results.
Four different operations were employed: simple mastectomy; mastectomy
and dissection of axilla; mastectomy, dissection of the axilla and removal of the
pectoralis major; and the classical radical mastectomy. Out of 599 operations
the last two formed the great majority; they were performed 108 and 456 times
respectively. Simple mastectomy was only performed on the very aged, and in
some cases where the carcinoma was only found on histological grounds after
operation for chronic mastitis.
The operative mortality for the whole series was-
15 in 599 cases 2.5 per cent.
4. Symptomatology.
The symptoms that occur between the onset of the disease and the start of
treatment can be divided into two types, the primary symptom and the secon-
dary symptom. The primary symptom is that which first draws the patient's
attention to the breast; the secondary symptom is that which occurs between
the primary symptoms and treatment. In this series there were 787 cases in
which the symptoms were recorded and they occurred with the following fre-
quency:
Percentage
frequency.
Initial symptom.
Lump noticed by patient . . . 83 5
Pain . . . . . . . 10
Discharge from nipple . . . . 3
Nipple retraction . . . . . 2
Lump noticed by doctor . . . 1
Ulceration . . . . . . 0 5
Secondary symptom.
Pain . . . . . . . 16
Discharge from nipple . . ..3.5
Nipple retraction . . . . . I
It will be seen that pain was the initial symptom in one out of ten cases and
was an initial or secondary symptom in one out of every four. This is higher
than would be expected from the usual teaching, and it would seem that painwas
a common finding in carcinoma of the breast. Its nature varied from a feeling
of discomfort to a definite sharp pain that might be referred down the arm. It
was not necessarily associated with glands in the axilla. It was difficult to
establish any connection between the degree of pain and the state of the growth.
Quite severe pain was found in some early cases, whereas, as is well known,
large tumours were often completely painless. The commonest type of pain was
the "niggling" or "nagging" feeling in the breast, intermittent in type.
Nipple retraction was a symptom in only 3 per cent of cases, but it was com-
monly found as a clinical sign. It would seem that women did not notice the
change in the nipple readily.
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The symptom/treatment interval.
The average delay between the onset of symptoms and reporting for treat-
ment in this series was 10 months (7718 months in 777 cases). As would be
expected, this interval was increased with the stages of the disease. Thus
Stage I cases had an average delay of 7 months, Stage II cases of 10 months and
Stage III cases of 18 months.
One can therefore reason that an average case has between 7 and 10 months'
grace before the catastrophe of axillary gland involvement takes place. Unfor-
tunately there is too much variance in individual growths for this figure to be of
anly real value. The one praptical point is the tragic length of delay before
seeking aid after the patient has noticed symptoms.
5. Recurrences: Their Distribution and Relation to the Site of the Primary Growth.
Information as to the site of recurrences was not always strictly accurate, as
a general practitioner might well mentiqn only the important recurrence, and
leave out less striking or lethal sites. The following table shows the incidence
and distribution of 647 recurrences:
Area ofrecurrence.
Skin:
Breast area
Multiple
Glandular:
Supraclavicular
Axillary .
Unspecified
Bone:
Vertebra
Pelvis
Leg.
Sternum
Arm
Skull
Others
Intrathoracic:
Lung
Mediastinum
Abdomen
Breast:
Homolateral
Contralateral
Brain .
Multiple .
Number.
138}142
91
. 39 133
. 3J
84
23
. 9
a. 9 132
. 2
2
. 23
· 3
6 129
. · 51
2035
, 15 3
10
. 151
Percentage.
_22
. 20.5
20.5
* 20
· 8
5.5
1.5
2
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Recurrences that are recorded under the heading of "Breast, homolateral"
are those in which there has been a return of activity after treatment by radio-
therapy. They should probably be called "insufficiently treated," but have
beenincluded in this analysis for convenience. Those underthe heading" Breast,
contralateral" are those in which the evidence strongly suggests a true recurrence
rather than a second primary.
The low incidence of mediastinal recurrences is probably due to the fact that
practitioners were likely to call any intrathoracic recurrences "pulmonary meta-
stasis." These figures, however, do not lend support to Rowlands and Turner
(1936), who state that the mediastinum is the commonest site for a recurrence.
This investigation has cleared up one point that has been debated in the past.
There is a direct path of spread from the breast to the supraclavicular glands.
Of 91 cases that developed recurrences in those glands 17 were Stage I cases,
treated by radical mastectomy, and with axillary glands proved to be free from
growth histologically. In view ofthe fact that the axillary glands were removed
at operation and that path ofspread permanently closed, the subsequent invasion
of the supraclavicular glands must have been through a more direct path.
Relation of site of primary growth to site of recurrence.
Some quadrants ofthe breast have been considered to be more likely to meta-
stasize in certain areas. Thus, inner quadrant growths have been held to give
secondaries in the chest more frequently. The percentage of pulmonary and
abdominal recurrences of all cases in each quadrant has been determined. The
results are as follows:
Percentage Percentage
Quadrant. giving pulmonary giving abdominal
metastasis. metastasis.
Upper and outer . . . -15 . 8.5
Inner and upper . . . 14.5 . 6.5
Central . . . . . 19 . 6.5
Upper and inner . . . 20 . 4
Inner and lower . . . 16 . 7-5
Axillary tail . . . . 215 . 7.5
There is no evidence in these figures to suggest that any quadrant ofthe breast
has an especial,tendency to metastasize to the chest or abdomen.
The interval between recurrence and death.
When attempting to give a prognosis in a case of carcinoma of the breast
that has developed secondaries, some guidance may be given by the average
interval in this series. It has been found to be close to 12 months for all stages
ofgrowth. The actual figures are:
Stage I . . . . . . 11.5 months.
Stage II . . . . . . 103 ,
Stage III . . . . . 125 ,,
It is ofsome interest to notice that delay in the onset of a recurrence does not
mean that that recurrence will be of less virulence. Recurrences in Stage I
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growths occurred much later than in the other stages but, once they were found,
the prognosis was equally bad.
This finding is in accordance with the clinical fact that cases in which the
recurrence has been delayed five or ten years are just as serious.
6. The Ten to Fifteen Year Period.
No surgeon who has followed cases of carcinoma ofthe breast can have failed
to see cases of recurrence occurring at long intervals after operation. These are
often regarded as interesting rarities. As a result of the long term follow-up of
the cases in this series it has been found that delayed recurrence is not rare.
The liability of recurrence in each five-year period after operation can be
determined by calculating the percentage of cases that develop a recurrence out
of the total of cases that were alive at the beginning of the period. This gives
the following interesting figures:
0-5 years . 394 recurrences in 734 cases . 53.5 per cent.
5-10 ,, . 50 ,, ,,199 , . 25 ,,
10-15 ,, . 11 ,, ,, 89 ,, . 125 ,,
This table shows that the tendency to develop a recurrence is less with each
five-year period, but is still very considerable after ten years. The actual number
that do develop these late recurrences is small owing to the cases that die early,
and this has given the false impression that survival to five years means that the
chance of recurrence is negligible. Doubt has long been cast on the term "five-
year cure rate." It would seem that the "ten-year cure rate" is equally value-
less. This investigation has forced one to the conclusion that, no matter how
early the case or thorough the treatment, no patient is free from the possibility
of recurrence until death occurs from some other cause.
SUMMARY.
1211 cases ofcarcinoma of the female breast have been analysed. The follow-
ing results have been found and conclusions drawn:
1. 72 per cent of all traced cases died from the disease within ten years.
2. The factor of overwhelming importance in the prognosis was the state of
the axillary glands.
3. Attachment to the deep tissues was of worse significance than attachment
to the skin.
4. Neither the situation of the primary nor the age of the patient appeared
to affect the prognosis to any marked degree.
5. Up to 1935 ancillaryradiotherapy to surgerygaveworseresults than surgery
alone. After 1936 changes in radiotherapeutic technique gave better results
than in the previous decade. There is insufficient evidence to show whether the
use ofradiotherapy improved the results of surgery.
6. Indirect evidence is produced to show that there is a direct channel of
spread between the breast and the supraclavicular glands.
7. The average length of life after the first sign of a recurrence, no matter
how long delayed, was approximately one year.
8. The liability to recurrence diminishes with each 5-year period after treat-
ment, but is still high 15 years after treatment.
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APPENDIX.
TABLE 1.-Effect of Clinical State of Growth at Start of Treatment. Stage 1: All
Treatments. Total, 250.
5 years. 10 years. Results
Number. Per cent. Number. Per cent.
Alive . . . . 115 46.0 . 51 20.4
Due to operation . . 7 2.8 . 7 2.8
Dead , carc. mammae . 75 30.0 . 96 38.4 unknown cause . 19 7.6 . 28 11-2-
, other cause . 8 3-2 . 9 3-6
Alive with recurrence . . 0 0.0 . 3 12
Untraced . . . . 26 10.4 . 56 22.4
TABLE II.-Stage II: All Treatments. Total, 484.
5 years. 10 years.
Results. N -
Number. Per cent. Number. Per cent.
Alive . . . . 84 17.3 . 38 7.8
rDueto operation . . 11 2.3 . 11 23
,, carc. manimae . 301 62-2 . 330 68-2 Dead ,, unknown cause . 23 4.8 . 30 6.2
, other cause . 30 6.6 . 35 7-2 Alive with recurrence . . 0 0.0 . 0 0.0
Untraced . . . . . 33 68 . 40 8.3ANALYSIS OF 1211 CASES OF BREAST CARCINOMA
TABLE III.-Stage Ila: All Treatments. Total, 24.
Results.
Alive
Due to operation
Dead
., carc. mammae ,,unknown cause
other cause
Alive with recurrence
Untraced .
5 years.
Number. Per cent.
2 8'3
0 0'0
17 70'8
3 12'5
1 4'2
0 0'0
1 4'2
10 years.
Number. Per cent.
2 8.3
O0 00
17 70'8
3 12'5
1 4.2
O 0-0
1 4.2
TABLE IV.-Stage IIIb: All Treatments. Total, 78.
Results.
Alive p
'Due to operation .
Dead ,, carc. mammiae
e,,a unknown cause
L ,, other cause Alive with recurrence
Untraced .
5 years.
Number. Per cent.
6 7'7
2 2'8
65 83.0
0 0.0
3 3.7
0 0.0
2 2.8
10 years.
Number. Per cent.
0
2
70
1
3
0
2
0.0
2.8
90 3
1.4
3.7
0.0
2.8
TABLE V.-Stage I: No Attachment and Slight Attachment.
Results.
Alive .
rDue to operation .
,, carc. mammae
Dead ,, unknown cause
lv ,, other cause
Alive with recurrence
Untraced .
No attachment.
5 years. 10 years.
65 29
3 3
31 44
9 12
3 3
0 0
14 34
Slight attachment.
5 years. 10 years.
54 24
4
40
9
6
0
12
4
52
15
7
0
23
TABLE VI.-Stage I: Early Attachment, Superficial and Deep.
Results.
Alive
From operation
rDead care. mammae
unknown cause .
,, other cause .
Alive with recurrence
Untraced . . .
Deep.
5 years. 10 years.
20 11
1
21
4
1
0
1
24
4
3
0
5 9
Skin.
5 years. 10 years.
33 13
3 3
19 28
9 12
1 2
0 0
8 15
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TABLE VII.-Site of Growth. Stage I Ca8es. Total, 240.
Inner and upper . . . . . . 48
Inner and lower . , . . . . 13
Outer and upper . . . . . . 89
Outer and lower . . . . . . 23
Axillary tail . . . . . . . 7
Central . . . . . . . 23
Mid-medial . . . . . . . 1
Mid-inferior . . . . . . . 7
Mid-lateral . . . . . . . 4
Mid-superior . . . . . . . 25
TABLE VIII.-Site of Growth. Stage II. Total, 450.
Inner and upper . . . . . . 60
Inner and lower .. 11
Outer and upper . . . . . . 184
Outer and lower . . . . . . 41
Axillary tail . . , . . . . 20
Central . . . . . . . 68
Mid-medial . . . . . . . 3
Mid-lateral . . . . . . . 21
Mid-inferior . .. 11
Mid-superior . . . . . . . 31
TABLE IX.-Mortality Rate for Each Age Group i
Stage I.
5 years. 10 years.
41 57
26 50
38 62
37 49
36 43
67 67
Stage II.
5 years. 10 years.
78 87
73 80
66 77
67 72
61 67
100 100
in Each Stage.
Stage III.
5 years. 10 years.
100 100
89 95
87 90
89 96
75 83
33 33
TABLE X.-Results According to Treatment. Stage I Growths.
Alive
From operation .
Dead ,, carc. mammae ,, other cause .
i ,, unknown cause
Untraced
Surgery Surgery
only.
an
only radium.
68 . 13
3 . 2
29 . 10
9
5
15
1
0
4
129 . 30 . 24 26
Age group.
0-39
40-49
50-59
60-69
70-79
80-89
Radio-
therapy
only.
* -D
* * g
Surgery,
radium,
DXR.
13
0
9
· 1
0
·
Surgery
and
DXR.
7
1
12
4
0
2
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TABLE XI.-Results According to Treatment. Stage II Growths.
Surgery Surgery Surgery and
only.
an only. radium
Alive . . . . 42 . 9
From operation .
. 2 . 6
IDead~ ,, carc. mammae . 99 . 38
Dead ~ ,, other cause . 6 . 2
,, unknown cause . 14 . 5
Untraced . . . . 20 . 7
Surgery,
radium,
DXR.
11
0
43
2
0
0
Surgery
and
DXR.
13
0
64
5
4
1
183 . 67 . 56 . 87 . 91
TABLE XII.-Mortality Rates for Various Treatment,
Treatment.
Surgery
Surgery and radium.
Surgery, radium and DXR
Surgery and DXR .
Radiotherapy
Percentage
mortality
rate.
5 years.
28
46
39
54
43
TABLE XIII.-Mortality Rates for Various Treatmen
Surgery
Surgery and radium.
Surgery, radium and DXR
Surgery and DXR
Radiotherapy . .
62
73
77
74
70
i. Stage I Growths.
Percentage
mortality
rate.
10 years.
49
68
50
67
86
8ts. Stage II Growths.
72
83
82
82
73
145
Radio-
therapy
only.
9
3
· 57
8
9
5